Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryusuke Hatae

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Neurologia Medico-Chirurgica|September 30, 2016
Current Trends and Healthcare Resource Usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: A National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor)Koji Yoshimoto, Akiko Kada, Daisuke Kuga, et al.
The British Journal of Radiology|February 9, 2022
Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomasHanae Takase, Osamu Togao, Kazufumi Kikuchi, et al.
Molecular Biology Reports|January 2, 2021
Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic deviceTakeo Amemiya, Nobuhiro Hata, Masahiro Mizoguchi, et al.
Journal of Neuro-Oncology|January 8, 2021
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluidYutaka Fujioka, Nobuhiro Hata, Yojiro Akagi, et al.
Neuro-Oncology Advances|July 18, 2024
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult gliomaRyosuke Otsuji, Nobuhiro Hata, Hidetaka Yamamoto, et al.
Brain Tumor Pathology|April 28, 2017
Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institutionKoji Yoshimoto, Ryusuke Hatae, Yuhei Sangatsuda, et al.
Clinical Neurology and Neurosurgery|October 23, 2019
Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization ClassificationYuhei Michiwaki, Nobuhiro Hata, Masahiro Mizoguchi, et al.
Neurologia Medico-Chirurgica|July 9, 2023
Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric StudyRyosuke Otsuji, Nobuhiro Hata, Yusuke Funakoshi, et al.
World Neurosurgery|December 27, 2021
Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective StudyYusuke Funakoshi, Kosuke Takigawa, Nobuhiro Hata, et al.
Journal of Neuro-Oncology|July 29, 2021
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastomaKosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Neurologia Medico-Chirurgica|September 30, 2016
Current Trends and Healthcare Resource Usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: A National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor)Koji Yoshimoto, Akiko Kada, Daisuke Kuga, et al.
The British Journal of Radiology|February 9, 2022
Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomasHanae Takase, Osamu Togao, Kazufumi Kikuchi, et al.
Molecular Biology Reports|January 2, 2021
Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic deviceTakeo Amemiya, Nobuhiro Hata, Masahiro Mizoguchi, et al.
Journal of Neuro-Oncology|January 8, 2021
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluidYutaka Fujioka, Nobuhiro Hata, Yojiro Akagi, et al.
Neuro-Oncology Advances|July 18, 2024
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult gliomaRyosuke Otsuji, Nobuhiro Hata, Hidetaka Yamamoto, et al.
Brain Tumor Pathology|April 28, 2017
Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institutionKoji Yoshimoto, Ryusuke Hatae, Yuhei Sangatsuda, et al.
Clinical Neurology and Neurosurgery|October 23, 2019
Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization ClassificationYuhei Michiwaki, Nobuhiro Hata, Masahiro Mizoguchi, et al.
Neurologia Medico-Chirurgica|July 9, 2023
Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric StudyRyosuke Otsuji, Nobuhiro Hata, Yusuke Funakoshi, et al.
World Neurosurgery|December 27, 2021
Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective StudyYusuke Funakoshi, Kosuke Takigawa, Nobuhiro Hata, et al.
Journal of Neuro-Oncology|July 29, 2021
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastomaKosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, et al.
Pageof 7